Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Federico P GómezRobert Rodríguez-Roisin

Abstract

Enhanced pulmonary production of nitric oxide (NO) has been implicated in the pathogenesis of hepatopulmonary syndrome (HPS). NO inhibition with N(G)-nitro-L-arginine methyl ester (L-NAME) in both animals and humans with HPS has improved arterial hypoxemia. We assessed the role of enhanced NO production in the pathobiology of arterial deoxygenation in HPS and the potential therapeutic efficacy of selective pulmonary NO inhibition. We investigated the effects of nebulized L-NAME (162.0 mg) at 30 and 120 minutes on all intrapulmonary and extrapulmonary factors governing pulmonary gas exchange in 10 patients with HPS (60 +/- 7 [SD] yr; alveolar-arterial oxygen gradient, range 19-76 mm Hg; arterial oxygen tension, range 37-89 mm Hg). Nebulized L-NAME maximally decreased exhaled NO (by -55%; P < .001), mixed venous nitrite/nitrate (by -12%; P = .02), and cardiac output (by -11%; P = .002) while increased systemic vascular resistance (by 11%; P = .008) and pulmonary vascular resistance (by 25%; P = .03). In contrast, ventilation-perfusion mismatching, intrapulmonary shunt and, in turn, arterial deoxygenation remained unchanged. In conclusion, gas exchange disturbances in HPS may be related to pulmonary vascular remodeling rather than...Continue Reading

References

Apr 1, 1991·The American Review of Respiratory Disease·P D Wagner, R Rodriguez-Roisin
Feb 10, 1966·The New England Journal of Medicine·P BerthelotL Reid
Oct 20, 1994·The New England Journal of Medicine·G RollaL Brussino
Nov 1, 1995·The European Respiratory Journal·G CremonaG J Jones
Mar 1, 1996·Clinics in Chest Medicine·A G AgustiR Rodriguez-Roisin
May 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S E BattagliaP W Angus
Aug 1, 1997·American Journal of Respiratory and Critical Care Medicine·J CardúsP D Wagner
Oct 27, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G RollaC Bucca
Jun 12, 1999·Journal of Hepatology·G MartinezR Rodriguez-Roisin
Oct 29, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·E P CarterI F McMurtry
Nov 14, 2000·Annals of Internal Medicine·P SchenkC Müller
Jul 4, 2001·Journal of Hepatology·G P MartínezR Rodriguez-Roisin
Aug 2, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G RollaC Bucca
Sep 11, 2001·American Journal of Respiratory and Critical Care Medicine·H NunesP Hervé
Jul 13, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Ethan P CarterIvan F McMurtry
Jun 8, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Yunchao SuEdward R Block
Sep 7, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Federico P GómezRobert Rodríguez-Roisin
Nov 2, 2004·The European Respiratory Journal·R Rodríguez-RoisinUNKNOWN ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee
Jan 11, 2005·The European Respiratory Journal·J M B Hughes
Feb 3, 2005·Gastroenterology·Miguel R ArguedasMichael B Fallon
Apr 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN European Respiratory Society

❮ Previous
Next ❯

Citations

Nov 6, 2007·Nature Clinical Practice. Gastroenterology & Hepatology·Catherine M Pastor, Eduardo Schiffer
Jul 4, 2012·Nature Reviews. Gastroenterology & Hepatology·Junlan Zhang, Michael B Fallon
May 30, 2008·The New England Journal of Medicine·Roberto Rodríguez-Roisin, Michael J Krowka
Apr 7, 2007·Current Opinion in Gastroenterology·Andres T Blei
May 17, 2011·Annals of Thoracic Medicine·Ali Nawaz KhanAlaa Gouda
Oct 9, 2013·BioMed Research International·Ahad EshraghianSeung Kew Yoon
Apr 26, 2014·Medizinische Klinik, Intensivmedizin und Notfallmedizin·T HorvatitsV Fuhrmann
Jun 2, 2009·Gastroentérologie Clinique Et Biologique·T ThevenotJ Cadranel
Dec 6, 2007·Journal of Clinical Gastroenterology·Ming-Hung Tsai
Apr 22, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael B Fallon
Apr 14, 2010·Journal of Viral Hepatitis·P SpagnoloR M du Bois
Mar 4, 2015·Digestive Diseases and Sciences·Yong Lv, Daiming Fan
Dec 17, 2009·São Paulo Medical Journal = Revista Paulista De Medicina·Liana Gonçalves de Macêdo, Edmundo Pessoa de Almeida Lopes
Apr 2, 2009·Seminars in Cardiothoracic and Vascular Anesthesia·Hanny YeshuaRan Oren
May 8, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sarah Raevens, Michael B Fallon
Jan 23, 2016·The European Respiratory Journal·Roberto Rodriguez-RoisinMichael J Krowka
Nov 30, 2012·Journal of Gastroenterology and Hepatology·Josephine A Grace, Peter W Angus
May 18, 2013·Hospital Practice·Ricardo RestrepoMichael Baram
Oct 29, 2013·European Journal of Anaesthesiology·Pascal FauconnetEduardo Schiffer
Jan 30, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Sarah RaevensIsabelle Colle
May 3, 2012·Journal of Breath Research·Caterina BuccaGiovanni Rolla
Dec 18, 2015·European Clinical Respiratory Journal·Andrei MalinovschiZuzana Diamant
Jul 20, 2016·World Journal of Gastroenterology : WJG·Israel Grilo-Bensusan, Juan Manuel Pascasio-Acevedo
Dec 7, 2013·Expert Review of Clinical Pharmacology·Thomas Horvatits, Valentin Fuhrmann
Apr 3, 2020·Scandinavian Journal of Gastroenterology·Søren MøllerFlemming Bendtsen
Jun 1, 2018·Case Reports in Critical Care·Caroline PhillipsLiam Ring
Mar 31, 2018·World Journal of Gastroenterology : WJG·Stergios SoulaidopoulosIoannis Goulis
Aug 25, 2014·Clinical Liver Disease·Valentin FuhrmannThomas Horvatits
Mar 11, 2015·Fundamental & Clinical Pharmacology·Monique Oswald-MammosserAnne Charloux
Sep 30, 2019·Clinics in Liver Disease·Rodrigo Cartin-Ceba, Michael J Krowka
Aug 22, 2021·Respiratory Medicine and Research·Catarina Aragon PintoAlice Gallo de Moraes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Federico P GómezRobert Rodríguez-Roisin
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Karen L SwansonM J Krowka
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Yiqun LingM B Fallon
© 2022 Meta ULC. All rights reserved